Back
Monster Beverage Corp. Vs. Monopar Therapeutics, Inc. Industry Stock Comparison
Buy
56
MNST
Monster Beverage Corp.
Last Price:
$76.2900
Seasonality Move:
14.82%
Sell
34
MNPR
Monopar Therapeutics, Inc.
Last Price:
$69.11
Seasonality Move:
25.93%
Buy
56
Monster Beverage Corp. (MNST)
is a Buy
Is Monster Beverage Corp. a Buy, Sell or Hold?
-
The current Monster Beverage Corp. [MNST] share price is $76.2600. The Score for MNST is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
MNST is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
Monopar Therapeutics, Inc. (MNPR)
is a Sell
Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Monopar Therapeutics, Inc. [MNPR] share price is $68.63. The Score for MNPR is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MNST Stock Price Chart
What is Monster Beverage Corp.'s stock price today?
-
The Monster Beverage Corp. share price today is $76.2600Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNST is experiencing slight buying pressure.
MNPR Stock Price Chart
What is Monopar Therapeutics, Inc.'s stock price today?
-
The Monopar Therapeutics, Inc. share price today is $68.63Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight buying pressure.
MNST Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.13 | Buy |
| Relative Strength Index (14 RSI): | 63.87 | Buy |
| Chaikin Money Flow: | 3851713 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (72.5468 - 75.1668) | Buy |
| Bollinger Bands (100): | (63.17 - 72.23) | Buy |
MNPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.61 | Sell |
| Relative Strength Index (14 RSI): | 37.25 | Sell |
| Chaikin Money Flow: | 166161 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (72.18 - 85.74) | Sell |
| Bollinger Bands (100): | (45.57 - 89.21) | Buy |
MNST Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 74.57 | Buy |
| 20-day SMA: | 74.29 | Buy |
| 50-day SMA: | 71.37 | Buy |
| 200-day SMA: | 63.95 | Buy |
| 8-day EMA: | 74.91 | Buy |
| 20-day EMA: | 73.94 | Buy |
| 50-day EMA: | 71.6 | Buy |
| 200-day EMA: | 64.67 | Buy |
MNPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 72.35 | Sell |
| 20-day SMA: | 78.65 | Sell |
| 50-day SMA: | 81.47 | Sell |
| 200-day SMA: | 52.32 | Buy |
| 8-day EMA: | 71.44 | Sell |
| 20-day EMA: | 75.9 | Sell |
| 50-day EMA: | 76.79 | Sell |
| 200-day EMA: | 56.68 | Buy |
Monster Beverage Corp. Earnings Growth & MNST Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.34 per share, and an increase next year of $0.24 per share.
Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.
Monster Beverage Corp. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Monopar Therapeutics, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||